American Herbal Products Association (AHPA) > Education > Webinars

Upcoming Webinars

Subscribe to AHPA Updates to be notified of upcoming AHPA events.

AHPA Webinar: Lacey Act Import Declaration Requirements

June 23, 2021 – 1-3pm EDT

The Lacey Act of 1900 (the Lacey Act) was originally passed to prohibit the interstate sale and transportation of game killed in violation of local laws. It was modified by the Food, Conservation and Energy Act of 2008 to also address illegal international logging practices and trade.

AHPA Webinar: Laying a Foundation for Success on Amazon

July 7, 2021 - 1 - 3pm EDT

p>With Amazon leading the charge as the industry leader in e-commerce, your brand’s customers are likely on Amazon. So, if you’re bypassing the Amazon marketplace as a means of distribution, you’re not meeting your customers where they shop.

AHPA Webinar: Product Safety Surveillance with the National Capital Poison Center

July 21, 2021 | 1 - 3pm EDT

webPOISONCONTROL® is a free online tool and app that provides immediate triage recommendations and automated follow up for acute, unintentional exposures to a vast array of products and substances.

RSS

Prior Webinars (Still available on demand)

Free webinar: Preparing for FDA cGMP Facility Inspections

Presented December 17, 2019

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of FDA inspections. This knowledge will assist businesses in better allocating and directing their compliance resources.

Webinar: Navigating the Maze of Claims in the Dietary Supplements Market

Presented March 25, 2020 -- Duration 2.5 hours

Learn from our panel that includes an industry attorney and scientist, who address legal standards, today’s regulatory environment, and the lawsuit risks and liabilities marketers face if claims are not adequately substantiated. The panel will also include an FTC representative, who provides the agency’s perspective, updates on recent enforcement actions, and a discussion of the level of substantiation respondents in those actions possessed or did not possess.

Webinar: FDA's Regulation of Cannabis Products, Including Hemp-CBD

Webinar: FDA's Regulation of Cannabis Products, Including Hemp-CBD

Presented February 13, 2020

Food and Drug Administration (FDA) Senior Advisor for Policy Sharon Mayl will provide Food and Beverage Industry Alliance (FBIA) members with an overview of the agency's regulation of cannabis products, including CBD products. This webinar is free to AHPA members.

Webinar: CA Prop 65 for Legal Cannabis Products

Presented February 26, 2020

This AHPA webinar reviews recent changes to CA Prop 65 and how other provisions of this state law apply to the legal cannabis industry, including marketers of hemp-derived CBD products.

Webinar: Compliance with FDA’s Revised Nutrition Labeling Regulations

Presented October 29, 2019

Recorded October 29, 2019, this webinar offers expert insights into the nutrition labeling requirements for foods and dietary supplements are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.

Webinar: Adverse Event Reports (AERs) and Recalls of Dietary Supplements

Presented October 1, 2019

Dr. Rick Kingston, an industry expert with more than 35-years of experience, presents on serious adverse event report (SAER) data and observations. Ashish Talati, a partner with Amin Talati & Wasserman and one of the industry’s foremost experts on FDA regulatory matters, joins Dr. Kingston to review dietary supplement legal and regulatory SAER obligations. In addition, AHPA Chief Information Officer Dr. Merle Zimmermann presents an overview of recent FDA recall data.
RSS
12

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.